D. I. C. SCOPES

2.4k citations

87 papers · 1.9k indexed · h-index 23

Molecular Biology top 10%
Organic Chemistry top 2%
Cellular and Molecular Neuroscience top 5%
Physiology top 10%
Pharmacology top 10%

Co-authors: Ann G. Hayes Nelson J. Leonard Duncan B. Judd Alan Naylor Hozefa Amijee M.B. Tyers Helen E. Connor M. Skingle
Topics: Synthesis and Biological Evaluation (14 papers)Alzheimer's disease research and treatments (12 papers)Receptor Mechanisms and Signaling (10 papers)
Cited by: Organic Chemistry Cellular and Molecular Neuroscience Molecular Biology
Journals: Science Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United Kingdom United States Bangladesh

In The Last Decade

D. I. C. SCOPES

80 papers receiving 1.8k citations

Peers

Countries citing papers authored by D. I. C. SCOPES

Since Specialization

Citations

This map shows the geographic impact of D. I. C. SCOPES's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. I. C. SCOPES with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. I. C. SCOPES more than expected).

Fields of papers citing papers by D. I. C. SCOPES

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. I. C. SCOPES. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. I. C. SCOPES. The network helps show where D. I. C. SCOPES may publish in the future.

Co-authorship network of co-authors of D. I. C. SCOPES

This figure shows the co-authorship network connecting the top 25 collaborators of D. I. C. SCOPES. A scholar is included among the top collaborators of D. I. C. SCOPES based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. I. C. SCOPES. D. I. C. SCOPES is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer’s disease 2017 ·Neuroscience Letters ·Daniela Brunner,Stefanie Flunkert,Joerg Neddens,(unknown),D. I. C. SCOPES,J. Mark Treherne,Birgit Hutter‐Paier	3
2	Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500 2013 ·Neuropharmacology ·Adrian C. Lo,Ina Tesseur,D. I. C. SCOPES,(unknown),Zsuzsanna Callaerts‐Vegh,Ben Vermaercke,J. Mark Treherne,Bart De Strooper,Rudi D’Hooge	11
3	Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease 2013 ·The International Journal of Neuropsychopharmacology ·Eugene O‘Hare,D. I. C. SCOPES,Eun‐Mee Kim,P. E. S. Palmer,David Spanswick,(unknown),Hozefa Amijee,(unknown),J. Mark Treherne,Ross Jeggo	10
4	Orally bioavailable small molecule drug protects memory in Alzheimer's disease models 2012 ·Neurobiology of Aging ·Eugene O‘Hare,D. I. C. SCOPES,Eun‐Mee Kim,P. E. S. Palmer,Martyn G. Jones,Andrew Whyment,David Spanswick,Hozefa Amijee,(unknown),(unknown),J. Mark Treherne,Ross Jeggo	14
5	Novel Anti-Inflammatory Compound SEN1176 Alleviates Behavioral Deficits Induced Following Bilateral Intrahippocampal Injection of Aggregated Amyloid-β1-42 2011 ·Journal of Alzheimer s Disease ·Eugene O‘Hare,D. I. C. SCOPES,J. Mark Treherne,John Monaghan,(unknown),Hozefa Amijee,Eun‐Mee Kim	21
6	RS-0406 Arrests Amyloid-β Oligomer-Induced Behavioural Deterioration In Vivo 2010 ·Behavioural Brain Research ·Eugene O‘Hare,D. I. C. SCOPES,J. Mark Treherne,(unknown),David Spanswick,Eun‐Mee Kim	16
7	Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor 2005 ·Bioorganic & Medicinal Chemistry Letters ·Stephen M. Courtney,(unknown),Richard T. Buck,(unknown),David J. Phillips,D. I. C. SCOPES,(unknown),Martin Pagé,James M. Bennett,(unknown),Edward A. McKenzie,(unknown),Robert Felix,Colin Stubberfield,Paul R. Turner	59
8	2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Stephen M. Courtney,(unknown),Richard T. Buck,(unknown),David W. Porter,D. I. C. SCOPES,(unknown),Martin Pagé,James M. Bennett,(unknown),Edward A. McKenzie,Colin Stubberfield,Paul R. Turner	42
9	Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1) 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael G. Orchard,(unknown),(unknown),Andrew N. Carr,David W. Porter,Paul Smith,D. I. C. SCOPES,David J. Haydon,Katherine A. Vousden,Colin Stubberfield,Kate Young,Martin Pagé	107
10	Glyco- and Peptidomimetics from Three-Component Joullié−Ugi Coupling Show Selective Antiviral Activity 2004 ·Journal of the American Chemical Society ·Timothy M. Chapman,(unknown),Baohua Gu,Timothy M. Block,D. I. C. SCOPES,(unknown),Stephen M. Courtney,Luke A. McNeill,Christopher J. Schofield,Benjamin G. Davis	71
11	4-[(Alkylamino)methyl]furo[3,2-c]pyridines: A New Series of Selective .kappa.-Receptor Agonists 1994 ·Journal of Medicinal Chemistry ·Alan Naylor,Duncan B. Judd,D. I. C. SCOPES,Ann G. Hayes,P.J. Birch	29
12	Bromobenzofuran-Based Non-peptide Antagonists of Angiotensin II: GR138950, a Potent Antihypertensive Agent with High Oral Bioavailability 1994 ·Journal of Medicinal Chemistry ·Duncan B. Judd,Michael D. Dowle,David Middlemiss,D. I. C. SCOPES,Barry C. Ross,(unknown),Martin Pass,(unknown),(unknown)	33
13	Evolution of a Novel Series of [(N,N-Dimethylamino)propyl]- and Piperazinylbenzanilides as the First Selective 5-HT1D Antagonists 1994 ·Journal of Medicinal Chemistry ·J. W. CLITHEROW,D. I. C. SCOPES,M. Skingle,Christopher Jordan,W. Feniuk,(unknown),(unknown),E. W. COLLINGTON,Helen E. Connor	89
14	A potent new class of .kappa.-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines 1993 ·Journal of Medicinal Chemistry ·Alan Naylor,Duncan B. Judd,(unknown),D. I. C. SCOPES,Ann G. Hayes,(unknown)	83
15	New .kappa.-receptor agonists based upon a 2-[(alkylamino)methyl]piperidine nucleus 1992 ·Journal of Medicinal Chemistry ·D. I. C. SCOPES,D. Neil Hayes,(unknown),David Belton,John Brain,Dearg S. Brown,Duncan B. Judd,Andrew B. McElroy,(unknown)	18
16	Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT₁ receptor antagonist 1992 ·British Journal of Pharmacology ·Mark J. Robertson,Jen Barnes,G.M. Drew,Kenneth L. Clark,Fiona H. Marshall,A.D. Michel,David Middlemiss,Barry C. Ross,D. I. C. SCOPES,Michael D. Dowle	66
17	GR94839, a κ‐opioid agonist with limited access to the central nervous system, has antinociceptive activity 1992 ·British Journal of Pharmacology ·H. L. Rogers,P.J. Birch,Susan M. Harrison,(unknown),Gary R. Manchee,Duncan B. Judd,Alan Naylor,D. I. C. SCOPES,Ann G. Hayes	34
18	Synthesis, antinociceptive activity and opioid receptor profiles of substituted trans-3-(decahydro- and octahydro-4a-isoquinolinyl)phenols 1992 ·Journal of Medicinal Chemistry ·Duncan B. Judd,Dearg S. Brown,(unknown),Andrew B. McElroy,D. I. C. SCOPES,P.J. Birch,Ann G. Hayes,Michael J. Sheehan	5
19	A series of novel, highly potent and selective agonists for the κ‐opioid receptor 1990 ·British Journal of Pharmacology ·Ann G. Hayes,P.J. Birch,Neil J. Hayward,Michael J. Sheehan,H. L. Rogers,M.B. Tyers,Duncan B. Judd,D. I. C. SCOPES,Alan Naylor	30
20	A novel elimination reaction of 3,4,6-tri--benzoyl-2,5-anhydro-D-allonic acid: ribosyl → 2′-deoxyribosyl conversion 1982 ·Tetrahedron Letters ·Lars J. S. Knutsen,Brian D. Judkins,Roger F. Newton,D. I. C. SCOPES	3

About D. I. C. SCOPES

D. I. C. SCOPES is a scholar working on Organic Chemistry, Toxicology and Pharmacology, having authored 87 papers that have together received 1.9k indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (14 papers), Alzheimer's disease research and treatments (12 papers) and Receptor Mechanisms and Signaling (10 papers). The work is most often cited by research in Organic Chemistry (772 citations), Cellular and Molecular Neuroscience (451 citations) and Molecular Biology (995 citations). D. I. C. SCOPES has collaborated with scholars based in United Kingdom, United States and Bangladesh. Frequent co-authors include Ann G. Hayes, Nelson J. Leonard, Duncan B. Judd, Alan Naylor, Hozefa Amijee, M.B. Tyers, Helen E. Connor, M. Skingle, W. Feniuk and Ian W. Davies. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact